Curosurf 80mg Injection

Overview Curosurf 80mg Injection

Surfactant replacement therapy, specifically Curosurf 80mg Injection, treats respiratory distress syndrome in premature infants. This medication addresses breathing difficulties stemming from insufficient lung surfactant. Administration is exclusively in a hospital setting under a healthcare professional's close observation. Dosage is determined by a physician based on the infant's condition. Continuous monitoring mitigates potential complications. Serious adverse events, including pneumothorax, intracranial hemorrhage, bronchopulmonary dysplasia, hypoxemia, and infection, may occur. Management of any side effects should be guided by your child's physician.

Primary Ingredients of Curosurf 80mg Injection

No information provided. Please provide the text you wish me to rephrase.

Uses of Curosurf 80mg Injection

Premature infant suffering from underdeveloped lungs, resulting in breathing difficulties.

Major Benefits of Curosurf 80mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Curosurf 80mg Injection:

• Pneumothorax
• Brain hemorrhage
• Chronic lung disease
• Hypoxia (decreased oxygen level in blood)
• Infection

How to use Curosurf 80mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Curosurf 80mg Injection works:

Premature infants often receive an 80mg injection of Curosurf to safeguard their developing lungs. This medication supplies a crucial fatty substance, a surfactant, which lines the air sacs. This lining prevents these sacs from collapsing and adhering during exhalation. Surfactant production by the baby’s own body typically begins only after the eighth month of gestation.

What if you forget to take Curosurf 80mg Injection :

Omit a dose of Curosurf 80mg Injection? Seek medical advice.